Search results for "Anemia"

showing 10 items of 352 documents

How to assess the risks associated with the usage of a medical device based on predictive modeling: the case of an anemia control model certified as …

2021

Background The successful application of Machine Learning (ML) to many clinical problems can lead to its implementation as medical devices (MD), being important to assess the associated risks. Methods An anemia control model (ACM), certified as MD may face adverse events as the result of wrong predictions that are translated into suggestions of doses of erythropoietic stimulating agents to dialysis patients. Risks are assessed as the combination of severity and probability of a given hazard. While severities are typically assessed by clinicians, probabilities are tightly related to the performance of the predictive model. Results A post-marketing dataset formed by all adult patients registe…

Adultmedicine.medical_specialtyAnemiabusiness.industryControl (management)Biomedical EngineeringAnemiaGeneral MedicineCertificationmedicine.diseaseHazardCohort StudiesMachine LearningRenal DialysisTest setCohortmedicineHematinicsHumansSurgeryIntensive care medicineAdverse effectRisk assessmentbusinessExpert review of medical devices
researchProduct

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.

2007

ABSTRACT Background A prospective phase II study was conducted to evaluate the efficacy and toxicity of the combination docetaxel (Taxotere) (DTX) and oxaliplatin (OXA) in ovarian cancer patients recurring after a platinum-free interval (PFI) >12 months. Patients and methods DTX, 75 mg/m2, was administered by 60 min i.v. infusion, followed by OXA, 100 mg/m2, given by a 2 h i.v., on day 1 every 21 days. Results From October 2003 to June 2006, 43 ovarian cancer patients were enrolled. Median PFI was 26 months. All patients were available for response evaluation: 17 complete responses and 12 partial responses were registered, for an overall response rate of 67.4%. The median response duration …

Adultmedicine.medical_specialtyOrganoplatinum CompoundsAnemiaSettore MED/06 - Oncologia MedicaOvarian cancer recurrencedocetaxel ovarian cancer recurrence oxaliplatinPhases of clinical researchDocetaxelGastroenterologyDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAgedOvarian NeoplasmsLeukopeniabusiness.industryHematologyMiddle Agedmedicine.diseaseOxaliplatinSurgeryOxaliplatinRegimenTreatment OutcomeOncologyDocetaxelDocetaxel; Ovarian cancer recurrence; OxaliplatinToxicityFemaleTaxoidsmedicine.symptomNeoplasm Recurrence LocalOvarian cancerbusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Oxygenation Status of Gynecologic Tumors: What is the Optimal Hemoglobin Level?

2002

Tumor hypoxia has been linked to the development of treatment resistance, tumor progression, and poor prognosis. Since anemia is a major causative factor for the development of hypoxia, the association between blood hemoglobin concentration (cHb) and tumor oxygenation was examined in this study.Pretreatment O(2) tension (pO(2)) measurements were performed in 59 primary carcinomas of the uterine cervix in which a stringent histopathologic examination of the electrode tracks was mandatory in order to exclude measurements in necrotic, stromal or normal cervical tissue. In addition, pO(2) readings in twelve primary cancers and 17 local recurrences of vulvar cancers were included in this study. …

Adultmedicine.medical_specialtyPathologyAnemiaUterine Cervical NeoplasmsCervix UteriGastroenterologyVulvaOxygen ConsumptionInternal medicineCarcinomamedicineHumansRadiology Nuclear Medicine and imagingAgedNeoplasm StagingVulvar NeoplasmsTumor hypoxiabusiness.industryMiddle AgedTumor OxygenationVulvar cancerHypoxia (medical)Prognosismedicine.diseaseCell HypoxiaTreatment OutcomeOncologyTumor progressionCarcinoma Squamous CellHemoglobinometryFemaleHemoglobinemiamedicine.symptombusinessStrahlentherapie und Onkologie
researchProduct

Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines.

2012

Hookworms produce a vast repertoire of structurally and functionally diverse molecules that mediate their long-term survival and pathogenesis within a human host. Many of these molecules are secreted by the parasite, after which they interact with critical components of host biology, including processes that are key to host survival. The most important of these interactions is the hookworm's interruption of nutrient acquisition by the host through its ingestion and digestion of host blood. This results in iron deficiency and eventually the microcytic hypochromic anemia or iron deficiency anemia that is the clinical hallmark of hookworm infection. Other molecular mechanisms of hookworm infec…

AncylostomatoideaVaccinesbiologyAnemia Iron-DeficiencyVirulenceImmunologyVirulenceHelminth geneticsHelminth Proteinsbiology.organism_classificationNecator americanusMicrobiologyHookworm InfectionsImmune systemAntigenAncylostomaHookworm InfectionsAntigens Helminthparasitic diseasesImmunologyImmunology and AllergyAnimalsHumansHookworm infectionThe Journal of allergy and clinical immunology
researchProduct

Un caso inusuale di malattia emolitica.

2007

Anemia emolitica
researchProduct

Anemia in non-celiac wheat sensitivity: Prevalence and associated clinical and laboratory features.

2022

Background: Patients suffering from non-celiac wheat sensitivity (NCWS) frequently report extra- intestinal symptoms, such as anemia. Aims: We investigated the prevalence and associated clinical features of anemia in NCWS patients. Methods: Data from 244 NCWS patients, diagnosed by double-blind placebo-controlled wheat challenge, were retrospectively reviewed and compared with 2 control groups (celiac disease (CD) and irritable bowel syndrome (IBS)). Furthermore, 31 NCWS anemic patients were prospectively re-evaluated after at least 12 months on the “strict”wheat-free diet (WFD). Results: Anemia prevalence in NCWS patients was 34.8% (mean hemoglobin 10.4 ±1.4 g/dl), significantly higher tha…

Anemia Iron deficiency Non-celiac wheat sensitivity Wheat-free dietSettore MED/09 - Medicina InternaHepatologyGastroenterologyDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Impact of anemia on long term prognosis of patients with STEMI treated with PCI and dual antiplatelet therapy

2016

Anemia on admission and Hb drop % are associated with worse long term prognosis and they are independent risk factor for adverse events in patient with STEMI treated with PCI and dual antiplatelet therapy.

Anemia STEMI
researchProduct

Murine Typhus and Hemophagocytic Syndrome

2018

No Abstract

Anemia030231 tropical medicineMEDLINEMurine typhusLymphohistiocytosis HemophagocyticMice03 medical and health sciences0302 clinical medicineAnti-Bacterial AgentmedicineAnimalsHumansAnimalbusiness.industryAnemiaTyphus Endemic Flea-BorneHematologymedicine.diseaseThrombocytopeniaAnti-Bacterial AgentsOncologyPediatrics Perinatology and Child HealthImmunology030211 gastroenterology & hepatologybusinessTyphusHumanJournal of Pediatric Hematology/Oncology
researchProduct

COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review

2020

Coronavirus disease-19 (COVID-19) has been regarded as an infective-inflammatory disease, which affects mainly lungs. More recently, a multi-organ involvement has been highlighted, with different pathways of injury. A hemoglobinopathy, hypoxia and cell iron overload might have a possible additional role. Scientific literature has pointed out two potential pathophysiological mechanisms: i) severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) interaction with hemoglobin molecule, through CD147, CD26 and other receptors located on erythrocyte and/or blood cell precursors; ii) hepcidin-mimetic action of a viral spike protein, inducing ferroportin blockage. In this translational medicine…

AnemiaFerroportinPharmacologymedicine.disease_causeHypoxemia03 medical and health sciencesiron0302 clinical medicinemedicine030304 developmental biology0303 health sciencesbiologyhypoxiabusiness.industryBrief ReportCOVID-19General MedicinehemoglobinHypoxia (medical)medicine.diseasePulmonary edemaHemoglobinopathybiology.proteinHemoglobinmedicine.symptombusiness030217 neurology & neurosurgeryOxidative stressClinics and Practice
researchProduct

Anemia of Chronic Disease: Pathophysiology and Laboratory Diagnosis

2005

Classic iron deficiency (ID) does not represent a challenge for the laboratory and physicians. The anemia that accompanies infection, inflammation, and cancer, commonly termed anemia of chronic disease (ACD), features apparently normal or increased iron stores. However, 20% of these patients have iron-restricted erythropoiesis (functional ID), an imbalance between the iron requirements of the erythroid marrow and the actual iron supply. Functional ID leads to a reduction in red cell hemoglobiniza-tion, causing hypochromic microcytic anemia. The diagnosis of functional ID in real time is based on measuring the hemoglobin content of reticulocytes. An examination of the biochemical markers of …

AnemiaIronClinical BiochemistrymedicineHomeostasisHumansErythropoiesisErythropoietinSoluble transferrin receptorbiologybusiness.industryBiochemistry (medical)AnemiaHematologyIron deficiencymedicine.diseaseHypochromic microcytic anemiaFerritinErythropoietinChronic DiseaseImmunologybiology.proteinErythropoiesisbusinessAnemia of chronic diseasemedicine.drugLaboratory Hematology
researchProduct